← Evidence map

TrialScientific reports2026

Acute and chronic dosing of the GABA A alpha 2,3 selective agonist BAER-101 do not alter behavior but may impact auditory-evoked EEG responses in adults with fragile X syndrome.

Lisa A De Stefano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Acute and chronic dosing of the GABA A alpha 2,3 selective agonist BAER-101 do not alter behavior but may impact auditory-evoked EEG responses in adults with fragile X syndrome. | OpenQuestion